Drug
Polyethylene glycol loxenatide clinical trials
Also written PEX168.
A product of Polyethylene Glycols; its studies count on that page too.
- studies test it
- 10
- open now
- 0
- in phase 3
- 3
- first study started
- 2011
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
10 studies that test it; most in 2015 (5)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 5 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 1
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 2
Jiangsu Hansoh Pharmaceutical Co., Ltd. (6) · Jiangsu HengRui Medicine Co., Ltd. (2) · Fudan University (1) · First Affiliated Hospital Xi'an Jiaotong University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses polyethylene glycol loxenatide is read from its arms, and is right about nine times in ten.
Testing it · 10
- Loxenatide Plus LNG-IUS in Endometrial Atypical HyperplasiaCompletedPhase 2/3Fudan UniversityNCT05172999Written as Polyethylene Glycol Loxenatide
- Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02447601Written as PEX168
- Evaluate the Pharmacokinetics of Digoxin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02472236Written as PEX168
- Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02461914Written as PEX168
- Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 PatientsStatus unknownPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02477865Written as PEX168(100µg)
- Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminStatus unknownPhase 3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02477969Written as PEX168(100µg)
- The Pharmacokinetic Study of the Combination of Digoxin and Polythylene Glycol Loxenatide Injection in Healthy SubjectsCompletedPhase 1First Affiliated Hospital Xi'an Jiaotong UniversityNCT02451527Written as PEX168
- Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal FunctionStatus unknownPhase 1Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT02467790Written as PEX168
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT01976858Written as PEX168
- A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT01965496Written as PEX168